The BeNeLuxA initiative, made up of Belgium, the Netherlands, Luxembourg and Austria, is continuing collaboration on improving access to costly, high-impact medicines and is now finalizing a proposal on how the four countries, and potentially others, could work together on horizon scanning.
The so-called BeNeLuxA Collaboration Initiative focuses on drugs with costs that “are expected to be disproportionately high per year or...








